Below you'll find a list of all posts that have been tagged as “life sciences”
Pharmaceutical competitive intelligence transforms raw competitor, regulatory, and market data into forward-looking strategic insight that helps life sciences companies anticipate competitor moves, shape evidence and launch planning, and make decisions that drive differentiated performance across the drug development lifecycle.
Competitive intelligence has become a strategic necessity in life sciences as pipelines grow more complex and competition accelerates. This article explores how CI teams are evolving to deliver earlier, more actionable insights that support high-stakes decision-making.
A global pharmaceutical company partnered with Sedulo to gain continuous visibility into competitive dynamics across four therapeutic areas. The result was faster BD scouting, clearer portfolio prioritization, and more confident strategic decisions.
Artificial intelligence is increasingly shaping life sciences competitive intelligence, but most organizations are still early in practical adoption. Sedulo Group’s research shows that while many CI teams see efficiency gains from AI, few have fully embedded it into standardized, decision-ready workflows.
The 2025 Life Sciences CI Survey Report reveals how CI functions are evolving, highlighting structural trends, the strategic value organizations place on early threat detection, and the growing yet measured role of AI in shaping competitive insight and decision-making across the industry.
A biopharma leader partnered with Sedulo on a multi-year competitive intelligence program to connect early clinical signals with commercial strategy. The engagement delivered continuous insights across 10 rare disease areas, enabling faster decisions, earlier warnings, and confident portfolio planning.
Bringing a new therapy to market is one of the riskiest bets in pharma, nearly one in three launches falls short of expectations, while 60% underperform when multiple therapies compete in the same space. Competitive intelligence (CI) isn’t just a tactical tool, when integrated early and continuously across development, it guides trial design, shapes payer strategy, and equips commercial teams to pivot ahead of competitive threats.
Pharmaceutical launches carry far-reaching risk and opportunity, demanding strategic precision from early development through to market entry. Sedulo’s guide outlines how integrating competitive intelligence, market insights, and cross-functional alignment across four stages can help transform high stakes into sustainable success.
Facing intensifying competition in the metabolic therapeutics arena, the pharma leader needed clear foresight into biosimilar threats, innovation pipelines, and competitor launch tactics. Through early-warning monitoring, primary intelligence, and deep landscape reporting, we helped them anticipate market shifts, align internal decision-makers, and fortify their leadership ahead of emerging disruptions.
Pharmaceutical companies need more than public data to stay ahead. Learn how integrating pharmaceutical primary intelligence fills critical gaps and uncovers real-time competitive insights.
